Be mindful that there's the possibilities of disruption(s)-
insert said reaction pathway[sake of conversation- transcription factor]. You may, or may not have seen I've mentioned this -
if a biochemical pathway (charted) directively creates a reaction. This doesn't necessarily mean it will happen. Nor does it tell us how quantitatively un/important it is. Be cognizant we're not living in a vacuum.
I'll pitch one particular transcription factor that's upregulated by uncontrolled OSA- sleep apnea. This isn't taking into account the probability of a laundry list of polypharmacy including nutraceuticals.
If curiosity piques your interest. Take a gander at how HIF1-a (hypoxia-inducible factor-1 alpha), could, theoretically bastardize mTORC1signalling. HIF-1a could very well put the brakes on mTORC1 activity under hypoxia-inducible factors by upregulating REDD1 (regulated in development and DNA damage responses 1). This by itself, could limit anabolic signalling. Under these same hypoxia-inducible factors, through a different pathway that intertwines with metabolism and anabolic pathways that very well could be disrupted; deiodinase activity (thyroid catalyzation) that facilities either activation and deactivation of thyroid hormones- T4, T3, rT3 and both isoforms of T2.
Then we have to account for inflammatory cytokines that theoretically could bastardize a-many more things. All relative to HIF1-a mucking up different hepatic and peripheral IGF-1 transcriptions.
Nevertheless it's good you’re engaging and digesting autodidactic learning